Table 6.
Anti-inflammatory effect of NSO on sub-acute inflammation.
| Time (h) | Paw Volume (ml) Mean ± SD and Inhibition Percentage (%) | ||||
|---|---|---|---|---|---|
| CTRL | CTRL+ | NSO_Prev | NSO_Treat | NSO_Adj | |
| 0 h | 3.5 ± 0.30 | 3.9 ± 0.44 | 3.3 ± 0.64 | 3.5 ± 0.43 | 3.4 ± 0.54 |
| 24 h | 7.4 ± 1.07 | 6.1 ± 0.99 * (17.1%) |
6.3 ± 1.05 (16.7%) |
6.5 ± 1.08 (9.7%) |
6.6 ± 0.84 (10.8%) |
| 72 h | 6.3 ± 0.94 | 5.4 ± 0.84 (15.7%) |
6.5 ± 0.70 - |
7.4 ± 1.34 - |
5.1 ± 0.56 * (20.1%) |
| 168 h | 5.8 ± 1.03 | 4.7 ± 0.67 * (16.7%) |
5.3 ± 1.05 (3.7%) |
5.9 ± 1.19 - |
4.5 ± 0.52 * (19.2%) |
Values are presented as mean ± SD (n = 10); * p < 0.05 significantly different from the control group.